RDY 18 (Methylphenidate Hydrochloride Extended-Release 18 mg)
Pill with imprint RDY 18 is Purple, Capsule-shape and has been identified as Methylphenidate Hydrochloride Extended-Release 18 mg. It is supplied by Dr. Reddy's Laboratories, Inc..
Methylphenidate is used in the treatment of adhd; narcolepsy; depression and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Methylphenidate 18 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for RDY 18
Methylphenidate Hydrochloride Extended-Release
- Imprint
- RDY 18
- Strength
- 18 mg
- Color
- Purple
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Cns stimulants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Dr. Reddy's Laboratories, Inc.
- National Drug Code (NDC)
- 43598-0438
Related Images for "RDY 18"
More about methylphenidate
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- 912 Reviews
- Drug class: CNS stimulants
Patient resources
- Drug Information
- Methylphenidate transdermal
- Methylphenidate Oral, Transdermal (Advanced Reading)
- Methylphenidate Transdermal (Advanced Reading)
- Methylphenidate Extended-Release Chewable Tablets
- Other brands
- Concerta, Ritalin, Quillivant XR, Daytrana, ... +11 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.